Susquehanna International Group, LLP Bausch Health Companies Inc. Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$5.22 - $8.26 $1.62 Million - $2.56 Million	310,000 Added 80.77%	693,800 $5.65 Million
Q2 2024 Aug 15, 2024	SELL	$6.1 - $10.41 $2.88 Million - $4.92 Million	-472,600 Reduced 55.18%	383,800 $2.68 Million
Q1 2024 May 07, 2024	SELL	$7.77 - $10.61 $19.8 Million - $27 Million	-2,548,600 Reduced 74.85%	856,400 $9.09 Million
Q4 2023 Feb 14, 2024	SELL	$6.53 - $8.23 $20,896 - $26,336	-3,200 Reduced 0.09%	3,405,000 $27.3 Million
Q3 2023 Nov 14, 2023	BUY	$7.69 - $9.71 $1.79 Million - $2.27 Million	233,300 Added 7.35%	3,408,200 $28 Million
Q2 2023 Aug 11, 2023	BUY	$5.72 - $8.8 $1.21 Million - $1.87 Million	212,400 Added 7.17%	3,174,900 $25.4 Million
Q1 2023 May 16, 2023	BUY	$6.28 - $9.85 $5.55 Million - $8.7 Million	883,300 Added 42.48%	2,962,500 $24 Million
Q4 2022 Feb 14, 2023	BUY	$6.09 - $7.93 $4.47 Million - $5.82 Million	733,300 Added 54.48%	2,079,200 $13.1 Million
Q3 2022 Nov 14, 2022	SELL	$4.58 - $9.21 $362,736 - $729,432	-79,200 Reduced 5.56%	1,345,900 $9.27 Million

255

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.07B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.